Aura Biosciences, Inc. Common Stock

AURANASDAQ • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
6.63 USD
↘ 0.17 (2.50%)AT CLOSE (11:59 AM EDT)
6.63
↘ 0.01 (0.08%)
POST MARKET (AS OF 04:37 PM EDT)
Post Market
AS OF 04:37 PM EDT
6.63
↘ 0.01 (0.08%)
🔴Market: CLOSED
Open?$6.80
High?$6.83
Low?$6.51
Prev. Close?$6.80
Volume?347.1K
Avg. Volume?673.1K
VWAP?$6.65
Rel. Volume?0.52x
Bid / Ask
Bid?$5.61 × 100
Ask?$7.49 × 100
Spread?$1.88
Midpoint?$6.55
Valuation & Ratios
Market Cap?685.5M
Shares Out?103.4M
Float?44.2M
Float %?68.9%
P/E Ratio?N/A
P/B Ratio?6.39
EPS?-$1.09
Dividend?0.00%
Ex-Dividend?N/A

AURA is currently priced at $6.63. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. AURA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
113
Market Cap
685.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.aurabiosciences.com
Listed
2021-10-29
Address
80 GUEST STREET
BOSTON, MA 02135
Phone: (617)500-8864
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
77
Short Sent.?
36
Piotroski F-Score?0/9Weak
Altman Z-Score?6.33Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?7.13%Elevated
Short Interest?3.2M
Days to Cover?2.8
Free Float44.2M
Avg Daily Volume1.1M
Settlement Date2026-05-15
Financial Health
Current Ratio?7.09Strong
Quick Ratio?7.09Strong
Cash Ratio?5.08Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
29
6.39FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-5.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-104.8%WEAK▾
ROA?
S&P
3
-81.6%WEAK▾
Cash Flow & Enterprise
FCF?$-91642000
Enterprise Value?$600.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist